News & Updates
Filter by Specialty:
Add-on radiation therapy poses higher cardiovascular risk in stage III NSCLC
The addition of radiation therapy to chemotherapy may be more detrimental than beneficial in patients with resectable stage III nonsmall‐cell lung cancer (NSCLC), being associated with a heightened risk of severe cardiac events, as shown in a study.
Add-on radiation therapy poses higher cardiovascular risk in stage III NSCLC
09 Dec 2022
Diabetes and COVID-19: What have we learned so far?
Evidence for excess risk and increased burden of new-onset diabetes among COVID-19 survivors is robust, and most antihyperglycaemic drugs can be used safely during acute COVID-19, with some drugs potentially offering protection against serious complications, according to data presented at 5th EDM HK.
Diabetes and COVID-19: What have we learned so far?
09 Dec 2022
Stroke up 30 percent since 2001 in HK’s ≤55-year-olds
Researchers from the University of Hong Kong (HKU) report that the incidence of “young stroke” (ie, strokes occurring in those aged 18–55 years) has increased by 30 percent in Hong Kong’s residents since 2001.
Stroke up 30 percent since 2001 in HK’s ≤55-year-olds
05 Dec 2022
Dose reduction needed in HFrEF patients on sacubitril-valsartan
Some patients with heart failure with reduced ejection fraction (HFrEF) need a loop diuretic dose reduction within 2‒3 months following initiation of sacubitril-valsartan, suggests a study.